CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients

Peer Review reports

Original Submission
3 Jul 2013	Submitted	Original manuscript
24 Nov 2013	Reviewed	Reviewer Report - Massimo Gion
26 Mar 2014	Author responded	Author comments - Mariarosaria Incoronato
Resubmission - Version 2
26 Mar 2014	Submitted	Manuscript version 2
12 May 2014	Author responded	Author comments - Mariarosaria Incoronato
Resubmission - Version 3
12 May 2014	Submitted	Manuscript version 3
Publishing
15 May 2014	Editorially accepted
21 May 2014	Article published	10.1186/1471-2407-14-356

Back to article page